Evidence map›Paper›PMID 22879600›Full record

ReviewThe Journal of biological chemistry2012

Corruption and spread of pathogenic proteins in neurodegenerative diseases.

Lary C Walker, Harry LeVine

Abstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Molecular crosstalk between cancer and neurodegenerative diseases.Cellular and molecular life sciences : CMLS · 2020
    Review
  12. Review
  13. Proteostasis collapse is a driver of cell aging and death.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  14. Neurotheranostics as personalized medicines.Advanced drug delivery reviews · 2019
    Review
  15. Biomarkers for tau pathology.Molecular and cellular neurosciences · 2019
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lary C WalkerYerkes National Primate Research Center and Department of Neurology, Emory University, Atlanta, Georgia 30329, USA. lary.walker@emory.edu
Harry LeVine

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
TROPIC, CHOLINERGIC AND PATHOLOGIC CHANGES IN ALZHEIMER'S DISEASEP01AG005119 · NIA · UNIVERSITY OF KENTUCKY · PI VAN ELDIK, LINDA J · 1985 to 2012
$15.4M
Cellular trafficking of pathogenic Abeta seeds in vitro and in vivoR21AG040589 · NIA · EMORY UNIVERSITY · PI BETARBET, RANJITA S, WALKER, LARY C · 2011 to 2012
$397k
NCRR NIH HHS P51RR165NIA NIH HHS P01 AG005119NIA NIH HHS P01AG005119NIA NIH HHS R21 AG040589NIA NIH HHS R21AG040589NIH HHS P51 OD011132NIH HHS P51OD11132
6 · The paper itself

Abstract

With advancing age, the brain becomes increasingly susceptible to neurodegenerative diseases, most of which are characterized by the misfolding and errant aggregation of certain proteins. The induction of aggregation involves a crystallization-like seeding mechanism by which a specific protein is structurally corrupted by its misfolded conformer. The latest research indicates that, once formed, proteopathic seeds can spread from one locale to another via cellular uptake, transport, and release. Impeding this process could represent a unified therapeutic strategy for slowing the progression of a wide range of currently intractable disorders.

Indexed as

AgingAmyloidogenic ProteinsAnimalsBrainHippocampusHumansHuntington DiseaseLewy Body DiseaseMiceMice, TransgenicNeurodegenerative DiseasesParkinson DiseasePrionsProtein BindingProtein ConformationProtein FoldingAmyloidogenic ProteinsPrions

Identifiers

PMID22879600
PMCPMC3460416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.